The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
Abstract: The cost of drug development is commonly cited between US$800 and US$1.8 billion. A similar statistic for vaccines is yet to be estimated, and it is unclear whether the cost of vaccines is similar to drug development. Financial and regulatory policy significantly impacts the extent and cost of pharmaceutical development, and as such it is important that…
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.
Speaker Biographies Keynote Speaker Louis Hugo Francescutti, MD, PhD, MPH, FRCPC, FACPM, CCFP, FRCP(Ire), FRCP(Edin), ICD-D, CCPEPresident, Canadian Medical Association, 2013-14 Dr. Louis Francescutti received his combined Doctor of Philosophy (Immunology) in 1985 and Doctor of Medicine in 1987 from the University of Alberta. In 1994, he completed further studies in injury control…
28 November 2013Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/81424176 Keynote presentation Let's Talk Health and Not HealthcareDr. Louis Hugo Francescutti, President, Canadian Medical AssociationDownload Presentation http://vimeo.com/channels/907291/81416417 Disclaimer:…
28 November 2013 Edmonton, Alberta Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation…
This report is an analysis of the theoretical basis for value-based pricing, relevant international developments, and areas for improvement within Canada’s current patented drug pricing system. This report intends to inform future policy research, advice, and Canadian drug policy discussions regarding the feasibility and implementation of value-based pricing approaches.
23 – 25 September 2013 Edmonton, Alberta IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Download the International Charter on the Prevention of FASD Well-known…
Plenary Speakers | Scientific Committee | Steering Subcommittee | Prevention Subcommittee | Organizing Committee Plenary Speakers Keynote Speaker Honorable Alison M. Redford, Q.C., Premier of Alberta, Canada Speakers Susan Astley, PhD, Research Affiliate at the Center on Human Development and Disability, University of Washington Ilona Autti-Rämö,…
Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013 First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 8:00 – 12:30 OPENING OF THE CONFERENCE Welcome from the Steering Committee of Alberta Initiatives on FASDEgon Jonsson and Marguerite Trussler http://vimeo.com/channels/907053/77103171 FASD Prevention in a Policy…
Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013| Other Presentations First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 13:30 – 15:00 PANEL A PRESENTATIONS Prevention of FASD in WA State: Evidence of Success (1973-2013) Dr. Susan Astley Download presentation (7.7 MB) Evaluating FASD Prevention…
Download the International Charter on the Prevention of FASD The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September…
Speakers | Jury | Steering Committee | Legal Subcommittee | Legal Working Group | Youth Ambassadors for FASD Working Group | Organizing Committee Planning for the Legal Issues Conference was carried out by a Subcommittee co-chaired by Kurt Sandstrom, Assistant Deputy Minister, Legal Services, Alberta Justice and Solicitor General; and Karen…
Program Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Download Program Consensus Statement Consensus Statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) 2013Download Consensus Statement Media Release 20 September 2013 – FASD Jury calls for changes to legal systemDownload Media Release Conference…
Reflections from the Conference Jury Chair: The Honourable Ian Binnie, C.C., Q.C, Former Justice of the Supreme Court of Canada What was the jury experience like at the FASD Conference?http://player.vimeo.com/video/80933845 What are you taking away from this conference?http://player.vimeo.com/video/80933844 Myles Himmelreich, Motivational Speaker What supports have helped you with…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Wed 18 Sep 2013 | Thu 19 Sep 2013 | Fri 20 Sep 2013 Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Wednesday, 18 September 2013 8:45 – 10:25 QUESTION 1: What are the implications of FASD for the legal system?a) An overview of FASD and its general implications An Introduction to FASDSterling Clarren, CEO and Scientific Director, Canada Northwest…
18 – 20 September 2013 Edmonton, Alberta Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges. Download…
| Angus Thompson, Philip Jacobs, Jessica Moffatt, Arianna Waye
This service and evaluation project originated from the Alberta courts via the collaboration of two Alberta Ministries; (1) Alberta Justice & Soliciter General and (2) Alberta Environment and Sustainable Resource Development. The impetus arose when a judge in an environmental protection case observed a need for additional attention to the mental health of workers. An Alberta…
| Thanh Nguyen, Jessica Moffatt, Philip Jacobs, Anderson Chuck, Egon Jonsson
Objectives: To estimate the break-even effectiveness of the Alberta Fetal Alcohol Spectrum Disorder (FASD) Service Networks in reducing occurrences of secondary disabilities associated with FASD.
Speaker Biographies Keynote Speaker Professor Sir Albert Aynsley-Green Kt.Children's Commissioner for England, 2005-2010 Sir Al Aynsley-Green is one of the world's leading authorities on children's services, child health and childhood. Through his distinguished early career as a pediatric endocrinologist and clinical researcher, he developed a deep interest in the circumstances…
9 May 2013Edmonton, Alberta Introductory Remarks Ms. Robyn Blackadar, President and CEO, Alberta Centre for Child, Family & Community Researchhttp://vimeo.com/channels/907291/66438458 Keynote Presentation Professor Sir Albert Aynsley-Green Kt. Children's Commissioner for England, 2005-2010http://vimeo.com/channels/907291/66486081 Response Dr. April Elliott, Chief…
9 May 2013 Edmonton, Alberta Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Key Forum Documents Innovation Forum IX – Early childhood…
5 May 2013 St. John's, Newfoundland The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable was a follow-up to a 2011 National Roundtable Discussion on Innovative Approaches to Industry-Payer Agreements held in Vancouver, British Columbia in association with the Canadian Agency for Drugs and Technologies in Health (CADTH) Annual Symposium.…
Biographies Hon. Fred Horne Minister of Health, Government of Alberta Mr. Horne was elected to his second term as a Member of the Legislative Assembly for Edmonton-Rutherford on April 23, 2012. On May 8, 2012, Mr. Horne was appointed as Minister of Health. He had served as Minister of Health and Wellness since October 2011. He also served as a member of the Cabinet Policy Committee…
Sunday, 5 May 2013 St. John's, Newfoundland Opening Remarks Anderson Chuck, Director of Economic Evaluation and Analytics, Institute of Health Economics Greetings from the IHE Board Mark Findlay, AstraZeneca, IHE Board Member Greetings from the Minister Honourable Fred Horne, Minister of Health, Alberta Outline of the Day Chris Henshall, Chair, HTAi Policy Forum Discussions on…
Roundtable Final Report Provincial Industry-Payer Agreements in an Era of National Pricing Strategies – National Roundtable Download Roundtable Final Report Program Provincial Industry Payer Agreements in an Era of National Purchasing Strategies – Program Download Program Background Document Industry-Payer Agreements for Pharmaceuticals: Backgrounder Download…
This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.…
Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…
The review summarizes the current evidence on the safety, efficacy, effectiveness, and potential cost-effectiveness on the use of the BridgePoint Medical System (consisting of the CrossBoss™ catheter, Stingray™ catheter, and Stingray™ guidewire) for the recanalization of refractory coronary chronic total occlusions (CTOs). The report also describes the relevant…
19 February 2013 Edmonton, Alberta The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory' concept builds off the recognition of the unique assets and opportunity we have in Alberta, including…
Biographies Dr. Lorne Tyrrell Board Chair, Institute of Health Economics Dr. Tyrrell is a former Dean of Medicine and Dentistry at the University of Alberta. He is a co-discoverer of the first oral antiviral drug to treat Hepatitis B. He is the CIHR/GlaxoSmithKline Chair in Virology at the U of A, Chair of the Gairdner Foundation, and a member of the Research Council of the Canadian…
Tuesday, 19 February 2013 Edmonton, Alberta Welcome Dr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://player.vimeo.com/video/60518479 Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM)Download Presentation http://player.vimeo.com/video/60607075 Greetings from the Government of…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada,…
| Sheri Pohar, Scot Simpson, Sumit Majumdar, Philip Jacobs, Arto Ohinmaa, William Osei, Mary Rose Stang, Winanne Downey, Jeffrey Johnson
Institute of Health Economics Working Paper WP 05-06. The purpose of this study was to analyze epidemiologic and cost trends from 1991 to 2001 in the province of Saskatchewan for a cohort of individuals identified as having diabetes and for a randomly selected control cohort. The objectives were to: explore epidemiologic trends (i.e., prevalence, incidence and mortality) in diabetes…
| Anita Simon, Robert Lee, David Cooke, Diane Lorenzetti
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #17. This paper focuses on incident reporting systems relevant to the hospital and efforts to improve patient safety and clinical outcomes. Costs associated with incident reporting systems are included wherever possible. This paper aims to assess the effectiveness of hospital incident reporting systems in improving…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #24. The objective of this paper is to present the current evidence on the efficacy/effectiveness and safety of celeoxib (Celebrex®) for the treatment of pain in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Information Specialist: Seana Collins NOTE: In 2006 the Alberta Heritage Foundation…